Literature DB >> 16739554

Treatments for chronic pain in persons with spinal cord injury: A survey study.

Diana D Cardenas1, Mark P Jensen.   

Abstract

BACKGROUND/
OBJECTIVE: To determine the degree and duration of pain relief provided by specific pain treatments used by individuals with spinal cord injury (SCI) who have chronic pain.
DESIGN: Postal survey.
SETTING: Community. PARTICIPANTS: Participants were 117 individuals who had traumatic SCI, were 18 years of age or older, and reported a chronic pain problem. MAIN OUTCOME MEASURES: Questions assessing current or past use of 26 different pain treatments, the amount of relief each treatment provided, and the length of time that any pain relief usually lasts.
RESULTS: The medications tried most often were nonsteroidal anti-inflammatory drugs (tried by 71%) and acetaminophen (tried by 70%); these medications were still being used by more than one half of the patients who had tried them. Opioids produced the greatest degree of pain relief on average (mean, 6.27 +/- 3.05 [SD] on a 0-10 scale, with 0 = no relief and 10 = complete relief) but were unlikely to be continued by those who tried them. Although 38% of respondents with pain had tried gabapentin, only 17% were still using it, and average pain relief was only moderate (mean, 3.32 +/- 3.03 on the 0-10 relief scale). Seventy-three percent of the respondents had tried at least 1 of 7 alternative pain treatments, and the most frequently tried were massage, marijuana, and acupuncture. The most relief was provided by massage (mean, 6.05 +/- 2.47] on the 0-10 relief scale) and marijuana (mean, 6.62 +/- 2.54 on the 0-10 relief scale). The relief from the various treatments, including most medications, tended to last only minutes or hours; however, pain relief from alternative treatments such as massage, acupuncture, and hypnosis was reported to last for days in 25% to 33% of those who tried these treatments.
CONCLUSIONS: Many patients are not finding adequate pain relief from commonly prescribed medications. Alternative therapies should be considered as additional treatment options in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739554      PMCID: PMC1864800          DOI: 10.1080/10790268.2006.11753864

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  38 in total

1.  Pain following spinal cord injury: results from a postal survey.

Authors:  M Rose; J E Robinson; P Ells; J D Cole
Journal:  Pain       Date:  1988-07       Impact factor: 6.961

2.  The perceived effects of marijuana on spinal cord injured males.

Authors:  M Dunn; R Davis
Journal:  Paraplegia       Date:  1974-11

Review 3.  The pharmacological management of chronic pain in the paraplegic patient.

Authors:  A E Farkash; R K Portenoy
Journal:  J Am Paraplegia Soc       Date:  1986 Jul-Oct

4.  Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.

Authors:  Funda Levendoglu; Cemile O Ogün; Onder Ozerbil; Tunç C Ogün; Hatice Ugurlu
Journal:  Spine (Phila Pa 1976)       Date:  2004-04-01       Impact factor: 3.468

5.  Cannabis effect on spasticity in spinal cord injury.

Authors:  J Malec; R F Harvey; J J Cayner
Journal:  Arch Phys Med Rehabil       Date:  1982-03       Impact factor: 3.966

6.  Psycho-social aspects of chronic pain in spinal cord injury.

Authors:  J S Richards; R L Meredith; C Nepomuceno; P R Fine; G Bennett
Journal:  Pain       Date:  1980-06       Impact factor: 6.961

7.  Neurophysiological approaches to chronic pain following spinal cord injury.

Authors:  W H Donovan; M R Dimitrijevic; L Dahm; M Dimitrijevic
Journal:  Paraplegia       Date:  1982-06

8.  Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study.

Authors:  G Davidoff; M Guarracini; E Roth; J Sliwa; G Yarkony
Journal:  Pain       Date:  1987-05       Impact factor: 6.961

9.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

10.  Comparing chronic pain from spinal cord injury to chronic pain of other origins.

Authors:  Michael J Cohen; David L McArthur; Michael Vulpe; Steven L Schandler; Kenneth E Gerber
Journal:  Pain       Date:  1988-10       Impact factor: 6.961

View more
  56 in total

1.  Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Brain Res       Date:  2011-07-26       Impact factor: 3.252

2.  Applications of complementary therapies during rehabilitation for individuals with traumatic Spinal Cord Injury: Findings from the SCIRehab Project.

Authors:  Sally M Taylor; Elaine O Cheung; Ruichen Sun; Veronika Grote; Anthony Marchlewski; Elizabeth L Addington
Journal:  J Spinal Cord Med       Date:  2018-06-08       Impact factor: 1.985

Review 3.  A systematic review of pharmacologic treatments of pain after spinal cord injury.

Authors:  Robert W Teasell; Swati Mehta; Jo-Anne L Aubut; Brianne Foulon; Dalton L Wolfe; Jane T C Hsieh; Andrea F Townson; Christine Short
Journal:  Arch Phys Med Rehabil       Date:  2010-05       Impact factor: 3.966

4.  Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Exp Neurol       Date:  2006-10-11       Impact factor: 5.330

Review 5.  Chronic complications of spinal cord injury.

Authors:  Nebahat Sezer; Selami Akkuş; Fatma Gülçin Uğurlu
Journal:  World J Orthop       Date:  2015-01-18

Review 6.  Physical activity interventions, chronic pain, and subjective well-being among persons with spinal cord injury: a systematic scoping review.

Authors:  Kendra R Todd; Sarah V C Lawrason; Robert B Shaw; Derrick Wirtz; Kathleen A Martin Ginis
Journal:  Spinal Cord       Date:  2020-09-18       Impact factor: 2.772

7.  Characteristics of Individuals with Spinal Cord Injury Who Use Cannabis for Therapeutic Purposes.

Authors:  Claudia Drossel; Martin Forchheimer; Michelle A Meade
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

8.  The reliability of end of day and ecological momentary assessments of pain and pain interference in individuals with spinal cord injury.

Authors:  Noelle E Carlozzi; Stephen Schilling; Jenna Freedman; Claire Z Kalpakjian; Anna L Kratz
Journal:  Qual Life Res       Date:  2018-08-02       Impact factor: 4.147

9.  Patients' perspectives on pain.

Authors:  Cecilia Norrbrink; Monika Löfgren; Judith P Hunter; Jaqueline Ellis
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

10.  Mental health and risk of secondary medical complications in adults with pediatric-onset spinal cord injury.

Authors:  Alicia M January; Kathy Zebracki; Kathleen M Chlan; Lawrence C Vogel
Journal:  Top Spinal Cord Inj Rehabil       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.